SCHEMBL8334258

SCHEMBL8334258

CCc1cccc(N(C(=N)N)c2cc(C(F)(F)F)ccc2Br)c1

nearest known ligand 0.48

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 18/20 0.48
GRIN2B Q13224 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27527832 0.87 SIGMAR1 (0.55) SIGMAR1
SCHEMBL27481516 0.84 SIGMAR1 (0.46) SIGMAR1
SCHEMBL7206334 0.82 SIGMAR1 (0.73) SIGMAR1
SCHEMBL27496660 0.81 SIGMAR1 (0.49) SIGMAR1
SCHEMBL27481517 0.80 SIGMAR1 (0.42) SIGMAR1
SCHEMBL8397630 0.77 SIGMAR1 (0.50) SIGMAR1
SCHEMBL5556091 0.77 SIGMAR1 (0.51) SIGMAR1GRIN2B
SCHEMBL27496997 0.76 SIGMAR1 (0.45) SIGMAR1GRIN2B
SCHEMBL27497654 0.75 SIGMAR1 (0.43) SIGMAR1
SCHEMBL6716755 0.75 SIGMAR1 (0.42) SIGMAR1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999002145-A1 COMBINATION DRUG THERAPIES COMPRISING AMINOGLYCOSIDE ANTIBIOTICS AND N,N'-DISUBSTITUTED GUANIDINES CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-01-21 WO claimed